It was previously reported that SS-31 protects against high-glucose-induced renal injury in diabetic nephropathy, inhibiting transforming-growth factor (TGF)-β1, NOX4, and thioredoxin-interacting protein (TXNIP) [130] (Table 1). Here, TXNIP is linked to diabetic kidney disease.